Financial reports
10-Q
2024 Q1
Quarterly report
6 Feb 24
ARS
2024 FY
Annual report to shareholders
29 Jan 24
10-K
2023 FY
Annual report
29 Nov 23
10-Q
2023 Q3
Quarterly report
7 Aug 23
10-Q
2023 Q2
Quarterly report
2 May 23
10-Q
2023 Q1
Quarterly report
6 Feb 23
10-K
2022 FY
Annual report
28 Nov 22
10-Q
2022 Q3
Quarterly report
4 Aug 22
10-Q
2022 Q2
Quarterly report
10 May 22
10-Q
2022 Q1
Quarterly report
2 Feb 22
Current reports
8-K
Submission of Matters to a Vote of Security Holders
19 Mar 24
8-K/A
Departure of Directors or Certain Officers
15 Mar 24
8-K
Departure of Directors or Certain Officers
21 Feb 24
8-K
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
6 Feb 24
8-K
Departure of Directors or Certain Officers
22 Jan 24
8-K
Entry into a Material Definitive Agreement
4 Jan 24
8-K
Changes in Registrant's Certifying Accountant
5 Dec 23
8-K
Arrowhead Pharmaceuticals Reports Fiscal 2023 Year End Results
29 Nov 23
8-K
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results
7 Aug 23
8-K
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results
2 May 23
Registration and prospectus
S-8
Registration of securities for employees
28 Feb 24
424B5
Prospectus supplement for primary offering
4 Jan 24
S-8
Registration of securities for employees
23 Mar 23
S-3ASR
Automatic shelf registration
2 Dec 22
S-8
Registration of securities for employees
22 Dec 21
S-8
Registration of securities for employees
18 May 21
424B5
Prospectus supplement for primary offering
5 Aug 20
S-8
Registration of securities for employees
22 May 20
424B5
Prospectus supplement for primary offering
4 Dec 19
424B5
Prospectus supplement for primary offering
2 Dec 19
Proxies
DEFA14A
Additional proxy soliciting materials
27 Feb 24
DEFA14A
Additional proxy soliciting materials
26 Jan 24
DEF 14A
Definitive proxy
26 Jan 24
DEF 14A
Definitive proxy
30 Jan 23
PRE 14A
Preliminary proxy
20 Jan 23
DEFA14A
Additional proxy soliciting materials
9 Mar 22
DEF 14A
Definitive proxy
26 Jan 22
DEF 14A
Definitive proxy
27 Jan 21
DEF 14A
Definitive proxy
28 Jan 20
PRE 14A
Preliminary proxy
14 Jan 20
Other
UPLOAD
Letter from SEC
19 May 23
CORRESP
Correspondence with SEC
18 Apr 23
UPLOAD
Letter from SEC
4 Apr 23
CORRESP
Correspondence with SEC
3 Mar 23
UPLOAD
Letter from SEC
10 Feb 23
UPLOAD
Letter from SEC
8 Mar 21
CORRESP
Correspondence with SEC
5 Feb 21
UPLOAD
Letter from SEC
27 Jan 21
CT ORDER
Confidential treatment order
18 Mar 19
UPLOAD
Letter from SEC
26 Mar 18
Ownership
SC 13G/A
VANGUARD GROUP INC
10 Apr 24
4
James C Hamilton
3 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
Hongbo Lu
20 Mar 24
3
Hongbo Lu
18 Mar 24
4
Kenneth Allen Myszkowski
8 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Christopher Richard Anzalone
2 Feb 24
144
Notice of proposed sale of securities
31 Jan 24